Researchers from the University of Texas analyzed health outcomes between 1,109 births in which the mother received the Tdap vaccine to 650 births in which the mother was not vaccinated. They found no differences in maternal and infant health outcomes that could be directly connected to the vaccine, meaning the vaccine is safe for both mothers and infants.
“Our study adds to the growing body of evidence that the Tdap vaccine is safe for pregnant women and their unborn children,” said Abbey Berenson, MD, PhD, the study’s lead author. “It’s important for women to get the Tdap vaccine while they are pregnant to protect their infants from pertussis.”
More articles on pertussis:
Key to optimizing the new pertussis vaccine might be going back to the old one
Zika, HPV, flu: 5 recent stories on vaccines
6 things to know about vaccine refusal, measles and pertussis
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.